BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 26997367)

  • 1. Targeting the 19S proteasomal subunit, Rpt4, for the treatment of colon cancer.
    Boland K; Flanagan L; McCawley N; Pabari R; Kay EW; McNamara DA; Murray F; Byrne AT; Ramtoola Z; Concannon CG; Prehn JH
    Eur J Pharmacol; 2016 Jun; 780():53-64. PubMed ID: 26997367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficient inhibition of human colorectal carcinoma growth by RNA interference targeting polo-like kinase 1 in vitro and in vivo.
    Xu WJ; Zhang S; Yang Y; Zhang N; Wang W; Liu SY; Tian HW; Dai L; Xie Q; Zhao X; Wei YQ; Deng HX
    Cancer Biother Radiopharm; 2011 Aug; 26(4):427-36. PubMed ID: 21797676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analyzing proteasomal subunit expression reveals Rpt4 as a prognostic marker in stage II colorectal cancer.
    McCawley N; Conlon S; Hector S; Cummins RJ; Dicker P; Johnston PG; Kay EW; McNamara DA; Prehn JH; Concannon CG
    Int J Cancer; 2012 Aug; 131(4):E494-500. PubMed ID: 21960357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calnexin, an ER stress-induced protein, is a prognostic marker and potential therapeutic target in colorectal cancer.
    Ryan D; Carberry S; Murphy ÁC; Lindner AU; Fay J; Hector S; McCawley N; Bacon O; Concannon CG; Kay EW; McNamara DA; Prehn JH
    J Transl Med; 2016 Jul; 14(1):196. PubMed ID: 27369741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histone deacetylase 2 regulates doxorubicin (Dox) sensitivity of colorectal cancer cells by targeting ABCB1 transcription.
    Ye P; Xing H; Lou F; Wang K; Pan Q; Zhou X; Gong L; Li D
    Cancer Chemother Pharmacol; 2016 Mar; 77(3):613-21. PubMed ID: 26846508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential role of TRIM3 as a novel tumour suppressor in colorectal cancer (CRC) development.
    Piao MY; Cao HL; He NN; Xu MQ; Dong WX; Wang WQ; Wang BM; Zhou B
    Scand J Gastroenterol; 2016; 51(5):572-82. PubMed ID: 26691157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased proteasome subunit protein expression and proteasome activity in colon cancer relate to an enhanced activation of nuclear factor E2-related factor 2 (Nrf2).
    Arlt A; Bauer I; Schafmayer C; Tepel J; Müerköster SS; Brosch M; Röder C; Kalthoff H; Hampe J; Moyer MP; Fölsch UR; Schäfer H
    Oncogene; 2009 Nov; 28(45):3983-96. PubMed ID: 19734940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of proteasomal degradation of Mcl-1 by cobalt chloride suppresses cobalt chloride-induced apoptosis in HCT116 colorectal cancer cells.
    Lee M; Lapham A; Brimmell M; Wilkinson H; Packham G
    Apoptosis; 2008 Aug; 13(8):972-82. PubMed ID: 18543107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Knockdown of the novel proteasome subunit Adrm1 located on the 20q13 amplicon inhibits colorectal cancer cell migration, survival and tumorigenicity.
    Chen W; Hu XT; Shi QL; Zhang FB; He C
    Oncol Rep; 2009 Feb; 21(2):531-7. PubMed ID: 19148532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RNAi-mediated gene silencing of vascular endothelial growth factor inhibits growth of colorectal cancer.
    Lv W; Zhang C; Zhou DH; Hao J; Sun JG; Liu T; Hao YX; Yu PW
    Cancer Biother Radiopharm; 2007 Dec; 22(6):841-52. PubMed ID: 18158776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RNA interference-mediated silencing of UBCH10 gene inhibits colorectal cancer cell growth in vitro and in vivo.
    Chen SM; Jiang CY; Wu JY; Liu B; Chen YJ; Hu CJ; Liu XX
    Clin Exp Pharmacol Physiol; 2010 May; 37(5-6):525-9. PubMed ID: 20529090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxaliplatin resistance induced by ERCC1 up-regulation is abrogated by siRNA-mediated gene silencing in human colorectal cancer cells.
    Seetharam RN; Sood A; Basu-Mallick A; Augenlicht LH; Mariadason JM; Goel S
    Anticancer Res; 2010 Jul; 30(7):2531-8. PubMed ID: 20682979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. microRNA-7 is a novel inhibitor of YY1 contributing to colorectal tumorigenesis.
    Zhang N; Li X; Wu CW; Dong Y; Cai M; Mok MT; Wang H; Chen J; Ng SS; Chen M; Sung JJ; Yu J
    Oncogene; 2013 Oct; 32(42):5078-88. PubMed ID: 23208495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of CLN3 silencing by RNA interference on the proliferation and apoptosis of human colorectal cancer cells.
    Zhu X; Huang Z; Chen Y; Zhou J; Hu S; Zhi Q; Song S; Wang Y; Wan D; Gu W; Zhou H; Zhang B; Cao W; He S
    Biomed Pharmacother; 2014 Apr; 68(3):253-8. PubMed ID: 24556023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PKM2 Subcellular Localization Is Involved in Oxaliplatin Resistance Acquisition in HT29 Human Colorectal Cancer Cell Lines.
    Ginés A; Bystrup S; Ruiz de Porras V; Guardia C; Musulén E; Martínez-Cardús A; Manzano JL; Layos L; Abad A; Martínez-Balibrea E
    PLoS One; 2015; 10(5):e0123830. PubMed ID: 25955657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Knockdown of human deubiquitinase PSMD14 induces cell cycle arrest and senescence.
    Byrne A; McLaren RP; Mason P; Chai L; Dufault MR; Huang Y; Liang B; Gans JD; Zhang M; Carter K; Gladysheva TB; Teicher BA; Biemann HP; Booker M; Goldberg MA; Klinger KW; Lillie J; Madden SL; Jiang Y
    Exp Cell Res; 2010 Jan; 316(2):258-71. PubMed ID: 19732767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting protein arginine methyltransferase 5 inhibits colorectal cancer growth by decreasing arginine methylation of eIF4E and FGFR3.
    Zhang B; Dong S; Zhu R; Hu C; Hou J; Li Y; Zhao Q; Shao X; Bu Q; Li H; Wu Y; Cen X; Zhao Y
    Oncotarget; 2015 Sep; 6(26):22799-811. PubMed ID: 26078354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A theranostic micelleplex co-delivering SN-38 and VEGF siRNA for colorectal cancer therapy.
    Lee SY; Yang CY; Peng CL; Wei MF; Chen KC; Yao CJ; Shieh MJ
    Biomaterials; 2016 Apr; 86():92-105. PubMed ID: 26896610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucose-regulated protein 78 silencing down-regulates vascular endothelial growth factor/vascular endothelial growth factor receptor 2 pathway to suppress human colon cancer tumor growth.
    Kuo LJ; Hung CS; Chen WY; Chang YJ; Wei PL
    J Surg Res; 2013 Nov; 185(1):264-72. PubMed ID: 23759331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted molecular therapy of the PI3K pathway: therapeutic significance of PI3K subunit targeting in colorectal carcinoma.
    Rychahou PG; Jackson LN; Silva SR; Rajaraman S; Evers BM
    Ann Surg; 2006 Jun; 243(6):833-42; discussion 843-4. PubMed ID: 16772787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.